EMV Capital plc

A deep tech and life sciences Venture Capital investment group

[EMV Capital plc @EMVCapital]

We’re excited to be a finalist at the @EISAssociation Awards 2025! In addition, 2 of our portfolio companies have been recognised - DeepTech Recycling MD’s Marvine Besong for Entrepreneur of the Year & @WandaHealth for Best EIS Investee Company

[EMV Capital plc @EMVCapital]

An update from @AMRBio, our portfolio co. advancing a a Phase 3-ready antimicrobial that rapidly eliminates harmful bacteria before it develops.

Next steps: FDA pathway guidance, manufacturing roadmap, and partnership conversations.

Announcement here: https://t.co/h4XKDes7jd

[EMV Capital plc @EMVCapital]

EMV Capital announces its 2025 Final Results, reporting continued progress despite ongoing VC and funding market challenges.

Join management as they present the results live at 10:30 BST today: https://t.co/eVeZOoDf3s

Read the full results here: https://t.co/ELpfGIbjmN

[EMV Capital plc @EMVCapital]

Join us for EMV Capital’s Final Results Presentation for the year ended 31 December 2025, tomorrow at 10:30 BST.

Management will share full-year results and portfolio progress across the EMV Capital EIS Fund and Martlet Capital Fund.

Register here: https://t.co/eVeZOoDf3s

[EMV Capital plc @EMVCapital]

Excited to invite you to a Virtual Meet the Portfolio session on Monday 1 December at 2:00pm GMT, hosted on @InvestorMeetCo.

Join us to learn how we identify, support, and scale IP-rich companies - and hear directly from the founders.

Register for free: https://t.co/eVeZOoDf3s

[EMV Capital plc @EMVCapital]

Delighted to announce the appointment of Anesh Patel as Group CFO with Stephen Crowe, the Company’s current CFO, transitioning to a newly created role of Portfolio CFO.

Both will be instrumental to our continued growth.

Read about the appointments here:
https://t.co/FXty5d6Eqq

[EMV Capital plc @EMVCapital]

Sofant Technologies has achieved a world-first by demonstrating a fully functioning Ka-band transmit array using its proprietary RF MEMS beamforming IC at Tech Tour Defence in Paris - a pivotal moment for wireless innovation. #EMVCapital #SatCom #5G #6G #Defence

[EMV Capital plc @EMVCapital]

Great to see @IChronicle highlight our 2025 half year results, noting that we are trading at a "tantalising discount" - with a fair valuation three times our current share price.

You can read the full article here: https://t.co/o7g9mdS5Yc

[EMV Capital plc @EMVCapital]

We are delighted to announce further progress in our 2025 Interim Results.

Highlights include:
- AUM: £104.7m
- £5m syndicated across 7 portfolio companies
- Martlet Capital fully integrated
- Destiny Pharma assets acquired

View full set of results here: https://t.co/7t5imv5n6I

[EMV Capital plc @EMVCapital]

In this interview our CEO discusses the acquisition of key Destiny Pharma assets.

We are applying our Venture Build Programme to identify, acquire, and rebuild value in the XF-73 drug platform, in the fight against antimicrobial resistance.

https://t.co/jgQmVHzuFZ

[EMV Capital plc @EMVCapital]

Excited to have acquired key assets from Destiny Pharma’s XF platform, incl. late-stage XF-73. This novel anti-infective targets post-surgical infections & antimicrobial resistance. #VentureCapital #HealthcareInnovation #AMR #LifeSciences

[EMV Capital plc @EMVCapital]

Delighted to announce that our portfolio company Wanda Health has secured £1.9M to scale remote patient monitoring and virtual care across the US. The investment round was led by EMV Capital Partners Ltd, and the funding will be used to accelerate growth.

https://t.co/KaYW7PCW47

[EMV Capital plc @EMVCapital]

Very happy to share that we have joined the @BVCA Investment Compact. A UK Government backed initiative to unlock £50bn of pension capital for high-growth UK companies.

Read more here: https://t.co/hrIk8Up2Kl

[EMV Capital plc @EMVCapital]

Our CEO @ILIAN_P_ILIEV joined @stevedarling at @proactive_UK to talk through our strong performance in 2024, following the release of preliminary results for our previous financial year, and outlined the strategic roadmap we are following in 2025.

https://t.co/23ivHp5bJh

[EMV Capital plc @EMVCapital]

Excited to report a 67% revenue rise in our FY24 results! Highlights: @MartletCapital integration, AUM up 33% to £98.5m (£103m by May 2), Fund Management launch, companies progressing to value inflection points, £1.5M raise at 15% premium.
Full results: https://t.co/WZklm5ob2H

[EMV Capital plc @EMVCapital]

We’re delighted to see @MartletCapital @EMVCapital portfolio company @allfocaloptics featured in @WIRED for pushing the boundaries of what’s possible in next-gen optics being applied to #AR #VR #XR. Read here: https://t.co/NaOl9y9iPL #CambridgeTech

[Vortex @VortexBioSci]

Our Director of R&D, Corinne Renier, is featured in the @IBIJournal, discussing non-invasive tumour profiling with liquid biopsy. 📖 Read the full article 👉 https://t.co/b5SWOccTGX #LiquidBiopsy #Oncology #CancerResearch #MedTech #BiotechUK

[Vortex @VortexBioSci]

Very excited to share that we are working with the @UMBaltimore to advance clinical investigations of Vortex's technology alongside UMB's pioneering Tetherchip research. This research team will gain unprecedented insights into #cancer biology https://t.co/nIRK8U5StW

[Hardman & Co @HardmanandCo]

Ilian Iliev of @EMVCapital, explains the unique #investment approach that’s fuelling #innovation in deep tech & #lifesciences. Discover how #AI, hardware, and international expansion are shaping the future of #venturecapital https://t.co/xNz2weE1nC

[EMV Capital plc @EMVCapital]

@EMVCapital @MartletCapital portfolio company @strolllapp has secured £10.3m of funding to accelerate its Digital Therapeutic software for Augmented Reality glasses for people with neuro-related disorders #Parkinsonsdisease #MS #VentureCapital